L.W. Chu
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Cancer, Lipids, and Metabolism
- Genetics top 5%
- Genomic variations and chromosomal abnormalities
Papers in
-
- Cancer Genomics and Diagnostics 4
- Cancer, Lipids, and Metabolism 2
- Genetics 5
- Genomic variations and chromosomal abnormalities 5
- Chronic Lymphocytic Leukemia Research 1
- Co-authors
- Jorma Isola (3 shared papers)Sandy DeVries (2 shared papers)Siavash Ghazvini (1 shared paper)F. Waldman (1 shared paper)Frederic M. Waldman (3 shared papers)S. G. Hilsenbeck (1 shared paper)C. Kent Osborne (1 shared paper)Olli Kallioniemi (1 shared paper)
- Journals
- Carcinogenesis (2 papers)Cytogenetic and Genome Research (2 papers)British Journal of Cancer (1 paper)Journal of Thoracic Oncology (1 paper)Prostate Cancer and Prostatic Diseases (1 paper)
- Partner nations
- United StatesTaiwanFinland
In The Last Decade
L.W. Chu
14 papers receiving 921 citations
Peers
Comparison fields: 5 of 83
- Cancer Research 349
- Genetics 368
- Pathology and Forensic Medicine 213
- Oncology 252
- Urology 38
Countries citing papers authored by L.W. Chu
This map shows the geographic impact of L.W. Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L.W. Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L.W. Chu more than expected).
Fields of papers citing papers by L.W. Chu
This network shows the impact of papers produced by L.W. Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L.W. Chu. The network helps show where L.W. Chu may publish in the future.
Co-authors
The 25 scholars most cited alongside L.W. Chu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Analysis of changes in DNA sequence copy number by comparative genomic hybridization in archival paraffin-embedded tumor samples. | 1994 | 340 |
| 2 | Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer. | 1995 | 263 |
| 3 | Genetic alterations in primary bladder cancers and their metastases. | 1998 | 84 |
| 4 | Genetic alterations in ERBB2-amplified breast carcinomas. | 1999 | 54 |
| 5 | 2012 | 51 | |
| 6 | 2011 | 49 | |
| 7 | 2013 | 41 | |
| 8 | 2010 | 27 | |
| 9 | 2006 | 11 | |
| 10 | 2006 | 11 | |
| 11 | 2010 | 8 | |
| 12 | 1996 | 3 | |
| 13 | 1994 | 1 | |
| 14 | 2018 | 1 |
About L.W. Chu
L.W. Chu is a scholar working on Cancer Research, Genetics, Molecular Biology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 14 papers that have together received 944 indexed citations. Recurring topics across this work include Genomic variations and chromosomal abnormalities (5 papers), Cancer Genomics and Diagnostics (4 papers), Genetic factors in colorectal cancer (3 papers), Cancer, Lipids, and Metabolism (2 papers), Biochemical Analysis and Sensing Techniques (1 paper), Neuropeptides and Animal Physiology (1 paper), Chronic Lymphocytic Leukemia Research (1 paper) and Genomics and Chromatin Dynamics (1 paper). The work is most often cited by research in Cancer Research (349 citations), Genetics (368 citations), Pathology and Forensic Medicine (213 citations), Oncology (252 citations) and Urology (38 citations). L.W. Chu has collaborated with scholars based in United States, Taiwan and Finland. Frequent co-authors include Jorma Isola, Sandy DeVries, Siavash Ghazvini, F. Waldman, Frederic M. Waldman, S. G. Hilsenbeck, C. Kent Osborne, Olli Kallioniemi, Suzanne A.W. Fuqua and Ann W. Hsing. Their work appears in journals such as Carcinogenesis, Cytogenetic and Genome Research, British Journal of Cancer, Journal of Thoracic Oncology and Prostate Cancer and Prostatic Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.